127 related articles for article (PubMed ID: 17320362)
1. A study of the formulation design of acoustically active lipospheres as carriers for drug delivery.
Fang JY; Hung CF; Liao MH; Chien CC
Eur J Pharm Biopharm; 2007 Aug; 67(1):67-75. PubMed ID: 17320362
[TBL] [Abstract][Full Text] [Related]
2. The effect of oil components on the physicochemical properties and drug delivery of emulsions: tocol emulsion versus lipid emulsion.
Hung CF; Fang CL; Liao MH; Fang JY
Int J Pharm; 2007 Apr; 335(1-2):193-202. PubMed ID: 17129692
[TBL] [Abstract][Full Text] [Related]
3. Acoustically active perfluorocarbon nanoemulsions as drug delivery carriers for camptothecin: drug release and cytotoxicity against cancer cells.
Fang JY; Hung CF; Hua SC; Hwang TL
Ultrasonics; 2009 Jan; 49(1):39-46. PubMed ID: 18554679
[TBL] [Abstract][Full Text] [Related]
4. Development and evaluation of emulsion-liposome blends for resveratrol delivery.
Hung CF; Chen JK; Liao MH; Lo HM; Fang JY
J Nanosci Nanotechnol; 2006; 6(9-10):2950-8. PubMed ID: 17048503
[TBL] [Abstract][Full Text] [Related]
5. Development and evaluation of perfluorocarbon nanobubbles for apomorphine delivery.
Hwang TL; Lin YK; Chi CH; Huang TH; Fang JY
J Pharm Sci; 2009 Oct; 98(10):3735-47. PubMed ID: 19156914
[TBL] [Abstract][Full Text] [Related]
6. Acoustically active lipospheres containing paclitaxel: a new therapeutic ultrasound contrast agent.
Unger EC; McCreery TP; Sweitzer RH; Caldwell VE; Wu Y
Invest Radiol; 1998 Dec; 33(12):886-92. PubMed ID: 9851823
[TBL] [Abstract][Full Text] [Related]
7. Stability, biocompatibility and antioxidant activity of PEG-modified liposomes containing resveratrol.
Caddeo C; Pucci L; Gabriele M; Carbone C; Fernàndez-Busquets X; Valenti D; Pons R; Vassallo A; Fadda AM; Manconi M
Int J Pharm; 2018 Mar; 538(1-2):40-47. PubMed ID: 29294324
[TBL] [Abstract][Full Text] [Related]
8. Submicron lipid emulsion as a drug delivery system for nalbuphine and its prodrugs.
Wang JJ; Sung KC; Hu OY; Yeh CH; Fang JY
J Control Release; 2006 Oct; 115(2):140-9. PubMed ID: 16959357
[TBL] [Abstract][Full Text] [Related]
9. Quality by design: characterization of self-nano-emulsified drug delivery systems (SNEDDs) using ultrasonic resonator technology.
Shah RB; Zidan AS; Funck T; Tawakkul MA; Nguyenpho A; Khan MA
Int J Pharm; 2007 Aug; 341(1-2):189-94. PubMed ID: 17521836
[TBL] [Abstract][Full Text] [Related]
10. A method for radiation-force localized drug delivery using gas-filled lipospheres.
Shortencarier MJ; Dayton PA; Bloch SH; Schumann PA; Matsunaga TO; Ferrara KW
IEEE Trans Ultrason Ferroelectr Freq Control; 2004 Jul; 51(7):822-31. PubMed ID: 15301001
[TBL] [Abstract][Full Text] [Related]
11. Controlling lipolysis through steric surfactants: new insights on the controlled degradation of submicron emulsions after oral and intravenous administration.
Wulff-Pérez M; de Vicente J; Martín-Rodríguez A; Gálvez-Ruiz MJ
Int J Pharm; 2012 Feb; 423(2):161-6. PubMed ID: 22209995
[TBL] [Abstract][Full Text] [Related]
12. Cetyl palmitate-based NLC for topical delivery of Coenzyme Q(10) - development, physicochemical characterization and in vitro release studies.
Teeranachaideekul V; Souto EB; Junyaprasert VB; Müller RH
Eur J Pharm Biopharm; 2007 Aug; 67(1):141-8. PubMed ID: 17346953
[TBL] [Abstract][Full Text] [Related]
13. Development and evaluation of lipid nanoparticles for camptothecin delivery: a comparison of solid lipid nanoparticles, nanostructured lipid carriers, and lipid emulsion.
Huang ZR; Hua SC; Yang YL; Fang JY
Acta Pharmacol Sin; 2008 Sep; 29(9):1094-102. PubMed ID: 18718178
[TBL] [Abstract][Full Text] [Related]
14. Characterization of gelation process and drug release profile of thermosensitive liquid lecithin/poloxamer 407 based gels as carriers for percutaneous delivery of ibuprofen.
Djekic L; Krajisnik D; Martinovic M; Djordjevic D; Primorac M
Int J Pharm; 2015 Jul; 490(1-2):180-9. PubMed ID: 26002567
[TBL] [Abstract][Full Text] [Related]
15. Design and in vivo pharmacodynamic evaluation of nanostructured lipid carriers for parenteral delivery of artemether: Nanoject.
Joshi M; Pathak S; Sharma S; Patravale V
Int J Pharm; 2008 Nov; 364(1):119-26. PubMed ID: 18765274
[TBL] [Abstract][Full Text] [Related]
16. Mixed lipid phase SMEDDS as an innovative approach to enhance resveratrol solubility.
Bolko K; Zvonar A; Gašperlin M
Drug Dev Ind Pharm; 2014 Jan; 40(1):102-9. PubMed ID: 23301796
[TBL] [Abstract][Full Text] [Related]
17. Encapsulating nanoemulsions inside eLiposomes for ultrasonic drug delivery.
Javadi M; Pitt WG; Belnap DM; Tsosie NH; Hartley JM
Langmuir; 2012 Oct; 28(41):14720-9. PubMed ID: 22989347
[TBL] [Abstract][Full Text] [Related]
18. Cremophor-free intravenous microemulsions for paclitaxel I: formulation, cytotoxicity and hemolysis.
Nornoo AO; Osborne DW; Chow DS
Int J Pharm; 2008 Feb; 349(1-2):108-16. PubMed ID: 17869459
[TBL] [Abstract][Full Text] [Related]
19. Application of liposome encapsulation technique to improve anti-carcinoma effect of resveratrol.
Lu XY; Hu S; Jin Y; Qiu LY
Drug Dev Ind Pharm; 2012 Mar; 38(3):314-22. PubMed ID: 21851312
[TBL] [Abstract][Full Text] [Related]
20. Preparation and in vitro characterization of chitosan nanobubbles as theranostic agents.
Cavalli R; Argenziano M; Vigna E; Giustetto P; Torres E; Aime S; Terreno E
Colloids Surf B Biointerfaces; 2015 May; 129():39-46. PubMed ID: 25819364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
